The frequency of measurements of vitamin D in the human population has significantly increased over the last decade because vitamin D has now been linked to many diseases, in addition to its established role in bone health. Usually, serum 25-hydroxyvitamin D concentrations are measured to assess the vitamin D status of individuals. Unfortunately, many studies investigating links between vitamin D and disease also use only this single metabolite. Intricate correlations with other vitamin D metabolites or dynamic effects of downstream metabolites may therefore be overlooked. Fortunately, powerful LC-MS/MS approaches have recently become available that can simultaneously quantify the concentrations of multiple vitamin D metabolites. These approaches are challenging, however, because of inherent instrumental problems with detection of vitamin D compounds and the low concentrations of the metabolites in biological fluids.
The term vitamin D describes a large class of secosteroids, of which the 2 most important representatives are vitamin D 2 and D 3 . While chemically very similar, both vitamers have entirely different biological origins; whereas D 3 is photosynthesized in mammals in their skin (1 ), D 2 mainly occurs in mushrooms (1 ) . Here we use the generic term vitamin D to describe the "human species" D 3 . D 2 is, of course, also active in humans and is sometimes used as food supplement and, therefore, D 2 is always specifically labeled in this review. Vitamin D is best known for its vital role in bone health (1 ) , but it has been linked to a much wider range of diseases, including diabetes, cancer, multiple sclerosis, depression, and cardiovascular diseases (2 ) .
Traditionally, the measurement of vitamin D compounds has been performed using methods such as immunoassays (3 ) or liquid chromatography (4 ); in fact, 90% of routine analyses today are performed by immunoassay techniques. In recent years, LC-MS/MS has been established as the gold standard technique for vitamin D analysis because of the technique's inherent analytical specificity and sensitivity (5 ) . Measurements of vitamin D species from biological fluids such as plasma or serum using mass spectrometry are not without challenges, however, for several reasons, including the lipophilic nature of the analytes, their tight binding to the carrier protein (e.g., vitamin D binding protein [DBP] 2 ), abundant isobaric and isomeric interferences in serum/plasma (6 ) , and the low ionization efficiencies for mass spectrometric analyses (7 ) Ideally, a true gold standard method for all vitamin D metabolites would cover all relevant high-and lowabundance species, using a universal and standardized analytical method. Although no simple assay solution for this purpose presently exists, several promising techniques have been reported over the last few years that demonstrate the future potential of mass spectrometry for comprehensive profiling of vitamin D metabolites (8, 9 ) . The role of LC-MS/MS in the determination of 25(OH)D has recently been reviewed by us (7 ) . The present review focuses on the mass spectrometric analysis of low-abundance vitamin D species beyond 25(OH)D and its future role in profiling and applications as well as clinical metabolomics.
Vitamin D Metabolism
The generation of vitamin D starts in the skin by sunlight photosynthesis. UVB radiation catalyzes conversion of 7-dehydrocholesterol to previtamin D, which then thermally converts to vitamin D. Excessive sun exposure degrades previtamin D and vitamin D into inactive photoproducts (1 ) . Vitamin D compounds predominantly bind to DBP, and to a lesser extent to albumin and lipoproteins, for circulation (10 ) . Vitamin D metabolism generates a number of different metabolites over a wide dynamic concentration range (2, 11 ) .
The first step in the metabolic pathway of vitamin D is conversion to 25(OH)D ( Renal production is influenced by multiple factors, including concentrations of serum phosphorus, calcium, and fibroblast growth factor 23 (FGF-23). 1,25(OH) 2 D also regulates its own synthesis through negative feedback; it also influences secretion of parathyroid hormone and expression of 25-hydroxyvitamin D-24 hydroxylase (24-OHase) (1 ) .
The human metabolism of vitamin D has been extensively studied, and Ͼ50 of circulating vitamin D metabolites have been described (12 ) . The actual number is even higher because of additional biochemical processes such as epimerization and lactonization (11 ) . As mentioned above, 25(OH)D is used to determine the vitamin D status of an individual, because only 25(OH)D has sufficiently high concentrations to be measured by routine assays and a sufficiently long half-life (approximately 19 days) in circulation to reflect sufficiency or deficiency in individuals (1 ) . Other downstream metabolites are often transient species that are usually present at much lower concentrations.
Importantly, to study the pathobiological role of vitamin compounds-including important low-abundant species-we need to know their concentrations. Therefore, we require very sensitive analytical methods to quantify the different vitamin D metabolites in relevant human tissues, which at the same time are selective enough to differentiate the various metabolic species. 
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Limitations of LC-MS/MS Assays
Current LC-MS/MS assays for vitamin D and its metabolites exhibit several areas of concern with the potential to negatively affect detection sensitivity, accuracy, and imprecision. These primarily relate to protein binding, ionization properties, and stabilities and interferences from isomers and isobars, as recently reviewed (7 ) . Briefly, the endogenous properties of vitamin D, such as its lipophilic nature and tight binding to DBP and albumin, have the potential to cause substantial matrix effects during sample extraction, which is usually performed using protein precipitation (PP), liquid-liquid extraction (LLE), solid-phase extraction (SPE), or combination of these techniques (13, 14 ) . Stable isotope standards of vitamin D compounds are essential to correct for analytical issues caused by ion suppression effects (7 ) . The isomeric and isobaric noise present in samples such as serum or plasma can lead to overestimation of 25(OH)D concentrations if compounds are not properly separated by liquid chromatography or if unspecific transitions are used for multiple reaction monitoring (MRM) during LC-MS/MS. Qi et al. recently provided a comprehensive characterization of isobaric and isomeric interferences in human serum, which have the potential to influence measured levels of 25(OH)D (6 ) .
Similarly, exogenous compounds such 1␣-hydroxyvitamin D 3 can inflate measured 25(OH)D concentrations when given to patients during management of secondary hyperparathyroidism in chronic kidney disease (13 ) . Finally, the C-3 epimer, 3-epi-25(OH)D, will also give overestimated 25(OH)D concentrations if not properly resolved by chromatography (vide infra) (7, 15, 16 (17 ) . PTAD has been shown to exhibit limited stability (18 ) ; improved versions were reported by Higashi et al. (17 ) . The same group also described an isotope-coded differential analog of PTAD for relative quantification (19 ) . Furthermore, a commercial derivatization reagent (Amplifex) is now available, which possesses a permanently charged quaternary ammonium group that substantially improves ionization efficiency (20 ) .
Analysis of Individual Vitamin D Species
In this section, we briefly review individual LC-MS/MS methodologies for quantitative analysis of important low-abundant vitamin D species, including 1,25(OH) 2 D, 3-epi-25(OH)D, 24,25(OH) 2 D, and other dihydroxylated species as well as transformation and conjugation products such as lactones and sulfates. The actual vitamin D species, i.e., the precursor compound before hydroxylation in the liver, has rarely been measured, except for a few studies concerned with breastfeeding mothers (21 ).
25(OH)D
The quantitative analysis of the main metabolite 25(OH)D has recently been thoroughly reviewed (7 ) and assays limited to 25(OH)D are therefore not included here. (24 ) . The mass spectrometry measurement problems discussed in the previous section equally apply to this vitamin D species, in particular the low ionization efficiency, which was improved by derivatization in one study (19 ) . The problem is further amplified by the short half-life of circulating 1,25(OH) 2 D of only 4 -6 h and the low physiological concentrations in the picomolar range (2 ) . In the case of 1,25(OH) 2 (27 ) . The method exhibited accurate (error Ͻ13.8%) and precise (CV Ͻ14.1%) concentration data, with an LLOQ of 5 pg/mL using an ESI triple-quadrupole mass spectrometer. (30 ) . The LOD for SPE-Amplifex was 1.9 pg/mL for 1,25(OH) 2 D 2 and 2.7 pg/mL for 1,25(OH) 2 D 3 ;LOQ was 4 pg/mL for both metabolites. The affinity extraction method gave an LOD of 2.7 pg/mL for 1,25(OH) 2 D 2 and 1.7 pg/mL for 1,25(OH) 2 D; the LOQ was 4 pg/mL for both metabolites.
3-EPI-25(OH)D
Additional vitamin D compounds are introduced by epimeric effects (Fig. 2) . Enzyme activity appears to be unidirectional and dependent on the presence of hydroxyl groups at C-1 or C-25, independent of cytochrome P450 enzymes (CYP 24, 27A1, and 27B1) and 3(␣,␤)-hydroxysteroid epimerase (31 ) .
Generally, 3-epi-25(OH)D concentrations decrease with age; concentrations are often high in infants (32 ) . It was hypothesized that hepatic immaturity may play a role in epimer production (22 ) , but substantial concentrations have also been found in adults (33 D (27 ) ; it was discovered that the concentrations of both compounds were significantly lower in the patients compared to healthy individuals. (18, 27, 40, 49 ) . For all methods, it is important to consider that the natural (R)-form and not the (S)-epimer is metabolically active (50 
(OH)DS was potentially helpful in assessing vitamin D status, especially in infants (19 ). The authors developed a simple and analytically sensitive method for 25(OH)DS in plasma using mixed-mode SPE and LC-MS/MS of the [M-H]
-ions in negative ionization mode. The LLOQ was reported as 2.5 ng/mL (19 ) .
NON-PROTEIN-BOUND VITAMIN D SPECIES
Almost all circulating vitamin D metabolites are bound to plasma proteins, mainly to DBP (approximately 85%) and albumin (approximately 14.6%). Only a small amount is freely available (0.4%) (59 ) . There is increasing interest in the measurement of free, non-proteinbound vitamin D metabolites, because they may better reflect the true vitamin D status in humans. Van Hoof et al. measured non-protein-bound plasma 1,25(OH) 2 D concentrations (60 ) . These authors developed a symmetric dialysis method by placing identical samples on both sides of a membrane and adding tritium-labeled 1,25(OH) 2 D to one side. The rate of transfer of the radiolabeled compound through the membrane was then related to the free amount of plasma 1,25(OH) 2 D (60 ).
Multimetabolite LC-MS/MS Assays
Currently, most research examining the link between disease and vitamin D focuses on the main vitamin D compound 25(OH)D, and intricate correlations with other metabolites or dynamic effects may therefore be overlooked. Multimetabolite LC-MS/MS methods have the ability to uncover such correlations, because all biologically relevant species are determined simultaneously within a single analysis, thus readily allowing interpretation of the vitamin D metabolite distributions as a func-tion of factors such as disease phenotype, progression, and treatment procedure. A single multimetabolite method offers the additional advantage of avoiding interassay analytical accuracy and imprecision issues when data from different assays are used for comparisons.
From such a multimetabolite assay, an inverse correlation between 1,25(OH) 2 D rather than 25(OH)D and pneumonia severity was observed, suggesting greater importance be placed on the biologically active form of vitamin D in these patients (61 ) . A number of studies have shown that serum 3-epi-25(OH)D (15, 22, 33 ) More interesting, of course, are profiling approaches that measure as many of the individual metabolites simultaneously as possible in human samples. We have summarized the most important recent studies for quantifying multiple vitamin D species in Table 1 . To aid the reader and contrast the different techniques, we have highlighted, for each assay, the vitamin D species monitored, the internal standard that was used, whether or not derivatization was used, the sample type and volume, sample preparation method, HPLC stationary and mobile phases, type of mass spectrometer and ionization technique, m/z transitions if multiple reaction monitoring (MRM) implemented, linear dynamic range, LLOQ, and precision of analysis.
In general, almost all of the assays in Table 1 use ESI for ionization and triple-quadrupole (QqQ) instruments as the mass analyzer. Most authors have used relatively unspecific H 2 O loss transitions in MRM for reasons of signal intensity (7 ) . Improved HPLC separation was often achieved using PFP columns as compared to the commonly used C-18 columns in other areas such as drug metabolism. Protein precipitation was initially carried out in all assays, followed mostly by SPE, with a few authors preferring LLE. (Fig. 4) . The study was performed with 8 healthy male study participants (age 22-35 years) after daily oral administration of 1000 IU vitamin D for 7 days (69 ) .
Almost all assays in Table 1 (71 ) . Although the excellent quantitative performance, particularly for the dihydroxylated vitamin D species, was not specifically mentioned by the authors, we suggest that this was likely due to the focused elution bands of chromatographic peaks achieved by the online Finally, Stiles et al. described population-based analytical measurements of Ͼ60 sterol and vitamin D derivatives and the correlation with genotype/phenotype information for a clinical cohort of 3230 individuals. The authors used LC-APCI-MS and found 27 sterols and vitamin D derivatives that were consistently detected with marked interindividual variation in their serum levels; the study also revealed genetic, anatomic, and clinical phenotypes that were associated with several of these lipids (Fig. 5) (80 ) .
Conclusions
Substantial advancements have been made in recent years in the measurement technology for vitamin D and its metabolites from biological fluids, with LC-MS/MS methods undoubtedly being the current gold standard technique for quantitative analysis. Importantly, to understand the pathobiological role and function of vitamin D, we need to know the concen- Values are partial correlation coefficients × 100 after adjustment for age, sex, and ethnicity between the indicated pairs of analytes and clinical parameters; r values for individual comparisons are depicted using a bipolar color progression as indicated by the scale below the figure. Only traits for which at least one r value was greater than or equal to ±10 are shown [reproduced with permission from Stiles et al. (79 ) ]. BMI, body mass index; HOMA IR, homeostatic model assessment of insulin resistance; ALP, alkaline phosphatase; AST, aspartate aminotransferase; GGT, ␥-glutamyltransferase; CK, creatine kinase; LD, lactate dehydrogenase; GFR MDRD, glomerular filtration rate according to the Modification of Diet in Renal Disease formula; BUN, blood urea nitrogen; TG, triglycerides; WBC, white blood cell.
trations of all relevant vitamin D metabolic species. Measuring 25(OH)D will always give only an incomplete picture that may or may not correlate with function in disease; rather, in our opinion, comprehensive chemical fingerprint (chemotype)/disease phenotype correlations are required in the future for vitamin D research. Unfortunately, the current state-of-the-art of mass spectrometric measurement assays do not allow quantitative measurement of all relevant species at the required LLOQ limits without using additional derivatization reagents to enhance response for the lowabundance metabolites. This derivatization step may become obsolete in the future, however, if more sensitive mass spectrometers become available or if more selective sample preparation procedures are used. 
